{"id":"W3176983361","doi":"10.1038/s41591-021-01369-8","title":"A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease","year":2021,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":365,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia; McGill University","funders":"Genentech; Korea Health Industry Development Institute; Deutsches Zentrum für Neurodegenerative Erkrankungen; Agence Nationale de la Recherche; GHR Foundation; Japan Agency for Medical Research and Development; Avid Radiopharmaceuticals; F. Hoffmann-La Roche; National Institute on Aging; Alzheimer's Association; Eli Lilly and Company; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Medicine; Asymptomatic; Placebo; Internal medicine; Cognitive decline; Oncology; Gastroenterology; Pathology; Disease; Dementia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0002757855,0.0002670374,0.0008215208,0.0003060113,0.00004303427,0.000006295634,0.0001258138,0.0002542602,0.001015606],"category_scores_gemma":[0.001517223,0.0001657566,0.0001482997,0.0009567301,0.0002354892,0.00006766852,0.00006815025,0.0007041681,0.00002058442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008205827,"about_ca_system_score_gemma":0.001303818,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008968019,"about_ca_topic_score_gemma":0.00009487763,"domain_scores_codex":[0.997421,0.0001532509,0.0005334333,0.0004644532,0.0009707573,0.0004570711],"domain_scores_gemma":[0.9980401,0.0002233166,0.0001202008,0.0006010829,0.0003547897,0.0006604585],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8284813,0.009371073,0.03626922,0.0007990488,0.01157881,0.06888239,0.0006412349,0.000001794383,0.00285899,0.0005818816,0.01300299,0.02753128],"study_design_scores_gemma":[0.7209056,0.008147785,0.2373684,0.004635358,0.007245314,0.0006074806,0.001016629,0.0003817186,0.009559008,0.0007060648,0.008743525,0.0006831134],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8715953,0.1149832,0.000005795714,0.00897216,0.0005291065,0.00146692,0.00007848589,0.0000573529,0.002311642],"genre_scores_gemma":[0.9963876,0.001400941,0.0001766854,0.0007522964,0.0004940401,0.00006519502,0.0003956807,0.0000367004,0.0002908718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2010991,"threshold_uncertainty_score":0.9998976,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04139425644428404,"score_gpt":0.3732302047329456,"score_spread":0.3318359482886616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}